In consideration that prognostic stratification was critical for determination of therapeutic regimens and improving survival for AML patients [8, 45–48], we determined the associations of DNMT3A single nucleotide polymorphisms (SNPs) with the prognosis of AML patients from southern China. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.